Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
4,715 results
- EHPOCIndependent statistical analysis of Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04793750).
- EHR-WWCIndependent statistical analysis of EHR Embedded Comparative Effectiveness Studies--WWC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04514679).
- ELARAIndependent statistical analysis of Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Electrical Stimulation for the Treatment of Back Pain Using Peripheral Nerve Stimulation (PNS): Complete Statistical AnalysisIndependent statistical analysis of Electrical Stimulation for the Treatment of Back Pain Using Peripheral Nerve Stimulation (PNS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ELEVATEIndependent statistical analysis of Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures: primary endpoint results, effect estimate with confidence interval,…
- Eltrombopag for Fanconi Anemia: Complete Statistical AnalysisIndependent statistical analysis of Eltrombopag for Fanconi Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03206086).
- Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy: Complete Statistical AnalysisIndependent statistical analysis of Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Eltrombopag Phase III Study In Chinese Chronic ITP Patients: Complete Statistical AnalysisIndependent statistical analysis of Eltrombopag Phase III Study In Chinese Chronic ITP Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01762761).
- Email Campaign to Increase Uptake of myGeisinger: Complete Statistical AnalysisIndependent statistical analysis of Email Campaign to Increase Uptake of myGeisinger: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04332614).
- EMAPIndependent statistical analysis of Esophageal Manometry During Recovery From Anesthesia: Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02661386).
- Embozene Microspheres for Uterine Fibroid Embolization (UFE): Complete Statistical AnalysisIndependent statistical analysis of Embozene Microspheres for Uterine Fibroid Embolization (UFE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01675011).
- EMERALDIndependent statistical analysis of Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE: primary endpoint results, effect estimate with confidence interval,…
- EMERALD-2Independent statistical analysis of A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EMERGEIndependent statistical analysis of Microenterprise Intervention to Reduce Sexual Risk Behaviors in Young Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03766165).
- Emergence Agitation Between Dexmedetomidine and Sevoflurane Anesthesia: Complete Statistical AnalysisIndependent statistical analysis of Emergence Agitation Between Dexmedetomidine and Sevoflurane Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06482125).
- EmiandMeIndependent statistical analysis of An Exploration of the Impact of Emicizumab on the Lives of People With Haemophilia and Inhibitors and Their Families: primary endpoint results, effect estimate with confidence interval, sample-size…
- EMMYIndependent statistical analysis of Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved): Complete Statistical AnalysisIndependent statistical analysis of EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- EMPIREIndependent statistical analysis of A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal Fistula: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EMPOWER-T2DIndependent statistical analysis of EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04531176).
- EMTIndependent statistical analysis of Enhanced Community-Based Asthma Monitoring Through Novel Technology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05824936).
- Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation: Complete Statistical AnalysisIndependent statistical analysis of Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05282459).
- ENB-GS-TBLB for the Diagnosis of PPLs: Complete Statistical AnalysisIndependent statistical analysis of ENB-GS-TBLB for the Diagnosis of PPLs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02207478).
- ENCOREIndependent statistical analysis of A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE): primary endpoint results, effect estimate with confidence…
- ENCOREIndependent statistical analysis of Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ENCORE-VTIndependent statistical analysis of Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ENDEAVORIndependent statistical analysis of Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle: Complete Statistical AnalysisIndependent statistical analysis of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ENDOMEDEIndependent statistical analysis of Clinical Performance and Safety Investigation of ENDOmetrial Washing MEdical DEvice Forielle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Endometrial Injury for Unexplained Infertility: Complete Statistical AnalysisIndependent statistical analysis of Endometrial Injury for Unexplained Infertility: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02863198).
- EndoRings Colonoscopy vs Standard Colonoscopy: Complete Statistical AnalysisIndependent statistical analysis of EndoRings Colonoscopy vs Standard Colonoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03418662).
- Endoscopic Therapy of Early Cancer in Barretts Esophagus: Complete Statistical AnalysisIndependent statistical analysis of Endoscopic Therapy of Early Cancer in Barretts Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00217087).
- Endovascular Denervation Improves Limb Ischemia in Patients With Peripheral Artery Disease: Complete Statistical AnalysisIndependent statistical analysis of Endovascular Denervation Improves Limb Ischemia in Patients With Peripheral Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts: Complete Statistical AnalysisIndependent statistical analysis of Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00583050).
- ENDURANCE-2Independent statistical analysis of A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection: primary endpoint results, effect estimate with confidence…
- ENDUREIndependent statistical analysis of A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis…
- ENESTPathIndependent statistical analysis of A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.: primary endpoint results, effect estimate…
- ENFORCEIndependent statistical analysis of A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ENGAGEIndependent statistical analysis of Engaging Patients in Tobacco Cessation Resources in Dental Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03656874).
- Engagement With an Adaptive Mobile Health Smoking Cessation Intervention: Complete Statistical AnalysisIndependent statistical analysis of Engagement With an Adaptive Mobile Health Smoking Cessation Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04020718).
- ENGAGESIndependent statistical analysis of Electroencephalography Guidance of Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02241655).
- ENHANCEIndependent statistical analysis of Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ENHANCE-ITIndependent statistical analysis of Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertriglyceridemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Enhancing Community Capacity to Improve Cancer Care Delivery: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Community Capacity to Improve Cancer Care Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04107116).
- Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B: Complete Statistical AnalysisIndependent statistical analysis of Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ENTRUST-AF-PCIIndependent statistical analysis of Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ENVISIONIndependent statistical analysis of A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Enzastaurin for Patients With Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Enzastaurin for Patients With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00192114).